Sabrina Galdo Novo

Mrs. Sabrina Galdo Novo


Research Focus & Metrics

Representative Publications

View All Publications
1 May 2014 in Vaccine
Verified
Journal Article
Closed access
EMEduardo Maradei
Eduardo Maradei
VMViviana Malirat
Viviana Malirat
CBClaudia Perez Beascoechea
Claudia Perez Beascoechea
AEAna María Espinoza
Ana María Espinoza
SNSabrina Galdo Novo
Sabrina Galdo Novo
IBIngrid E. Bergmann
Ingrid E. Bergmann

1 September 2017 in Vaccine
Verified
Journal Article
Closed access
JHJacquelyn Horsington
Jacquelyn Horsington
CPClaudia Beascoechea Perez
Claudia Beascoechea Perez
EMEduardo Maradei
Eduardo Maradei
SNSabrina Galdo Novo
Sabrina Galdo Novo
Jose L GonzalesJose L Gonzales
Jose L Gonzales
WVWilna Vosloo
Wilna Vosloo

12 August 2023 in Vaccine
Verified
Journal Article
Closed access
VMViviana Malirat
Viviana Malirat
CCCecilia Caldevilla
Cecilia Caldevilla
SCSabrina Cardillo
Sabrina Cardillo
AEAna María Espinoza
Ana María Espinoza
SNSabrina Galdo Novo
Sabrina Galdo Novo
IBIngrid E. Bergmann
Ingrid E. Bergmann

10 February 2024 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
ATAna I. Taffarel
Ana I. Taffarel
MBMelanie Y. Barrios Benito
Melanie Y. Barrios Benito
VHVo V. Hung
Vo V. Hung
SCSabrina Cardillo
Sabrina Cardillo
NPNguyen T. Phuong
Nguyen T. Phuong
SNSabrina Galdo Novo
Sabrina Galdo Novo

4 November 2024 in Viruses
Verified
Journal Article
Open access
PDF file
MMMaría Cruz Cruz Miraglia
María Cruz Cruz Miraglia
MBMelanie Yazmin Barrios Benito
Melanie Yazmin Barrios Benito
SNSabrina Galdo Novo
Sabrina Galdo Novo
DBDanilo Bucafusco
Danilo Bucafusco
ATAna Inés Taffarel
Ana Inés Taffarel
Daniel Mariano Pérez-FilgueiraDaniel Mariano Pérez-Filgueira
Daniel Mariano Pérez-Filgueira
The high antigenic variability of the foot-and-mouth disease virus (FMDV) represents a challenge for developing prophylactic strategies, stressing the need for research into vaccines offering broad protection against a range of virus strains. Here, the heterotypic cross-reaction using different vaccine schemes against serotype O strains was studied, evaluating the impact of revaccination, antigen dose, and incorporation of additional FMDV serotypes. Naïve cattle were immunized with seven distinct FMDV vaccines, receiving three doses of the same formulation at 0, 28, and 56 days post-primary vaccination (dpv). Serum samples were collected up to 70 dpv and tested by a virus-neutralizing test against serotype O strains from a South American lineage and two strains representative of two Asian lineages. Our results showed that vaccines containing the ME-SA topotype O1/Campos strain developed cross-neutralizing responses against the two Asian viruses after the first vaccination. In contrast, significant heterotypic neutralizing antibody titers against the homologous topotype strain were only found after the second vaccination, indicating that the phylogenic relationship may differ from the antigenic profiles for these two viruses. The amount of the O1/Campos strain and the revaccination were essential factors for neutralization against the homologous- and heterologous-type O FMDV viruses. The strain composition of the vaccine was only relevant for cross-neutralization against one of the Asian strains, suggesting potential intra-serotypic divergences for this pattern.

24 July 2025 in Viruses
Verified
Journal Article
Open access
PDF file
ALAnthony Loor
Anthony Loor
SNSabrina Galdo Novo
Sabrina Galdo Novo
LNLuis Nuñez
Luis Nuñez
Enteric diseases represent one of the main causes of morbidity and mortality in poultry production, especially in turkeys (Meleagris gallopavo), significantly affecting the profitability of the sector. Turkey enteric complex (PEC) is a multifactorial syndrome characterized by diarrhea, stunting, poor feed conversion, and increased mortality in young turkeys. Its aetiologia includes multiple avian enteric viruses, including astrovirus, rotavirus, reovirus, parvovirus, adenovirus, and coronavirus, which can act singly or in co-infection, increasing clinical severity. This study performs a systematic review of the literature on these viruses and a meta-analysis of their prevalence in different regions of the world. Phylogenetic analyses were used to assess the genetic diversity of the main viruses and their geographical distribution. The results show a wide regional and genetic variability, which underlines the need for continuous epidemiological surveillance. Health and production implications are discussed, proposing control strategies based on biosecurity, targeted vaccination, and optimized nutrition. These findings highlight the importance of integrated management to mitigate the impact of CSF in poultry.